Immune Deficiency Foundation

Recent papers from Immune Deficiency Foundation

1. HLA-A*11:01-Restricted T Cell Receptors Targeting Mutant NPM1 for Adoptive Cell Therapy in Acute Myeloid Leukemia2026
2. Epidemiologic and clinical characteristics of Mycobacterium tuberculosis infection in Guangxi, China, 2018-2023: a retrospective studyFrontiers in Cellular and Infection Microbiology · 2026
3. Respiratory profile of pediatric patients undergoing hematopoietic stem cell transplantation studied by oscillometry – A TRANSPIRE cohortPediatric Investigation · 2026
4. Inborn errors of immunity in Low German Mennonite communities in Mexico: a case series and narrative literature reviewFrontiers in Immunology · 2026
5. Heterogeneous immune cell composition in patients with combined immunodeficiencyFrontiers in Immunology · 2026
6. IMPACT (Immune Monitoring and Phenotype Assessment of Clinical Trajectory) for Patients With Inborn Errors of Immunity From the Primary Immune Deficiency Treatment Consortium (PIDTC)The Journal of Allergy and Clinical Immunology In Practice · 2026
7. Baricitinib for refractory chronic graft-versus-host-disease: Results of a phase 1/2 study.Blood Advances · 2026
8. XIAP Deficiency Caused by a Deletion in the Noncoding Exon 1 Identified by Chromosomal MicroarraySHILAP Revista de lepidopterología · 2026
9. Integrating Functional, Structural, and Predictive Data in the Analysis of the Recombination Activating Gene (RAG) Genomic VariantsSHILAP Revista de lepidopterología · 2026
10. Targeting the IL-8 axis in high-risk myelodysplastic syndromes: a clinical experience with antibody blockade combined with decitabine/cedazuridineLeukemia & lymphoma/Leukemia and lymphoma · 2026
11. Immunotherapy in acute myeloid leukemia: The antibodies, TriKEs, and CARs on the arduous road to cureBlood Reviews · 2026
12. Critical Considerations in Helicopter Evacuation of Injured Personnel From Combat ZonesPrehospital and Disaster Medicine · 2026
13. Continuous O ₂ /H ₂ O ₂ -Evolving Hollow Manganese Ferrite Nanocomposite for Cancer Synergistic Enhanced Chemodynamic/Photothermal/Starvation TherapyACS Applied Materials & Interfaces · 2026
14. Autoimmunity in Patients with Wiskott-Aldrich Syndrome (WAS) after Hematopoietic Stem Cell Transplantation (HSCT)- a Single Center ExperienceTransplantation and Cellular Therapy · 2026
15. Medical Algorithm: Personalized Immunoglobulin Replacement Therapy for Inborn Errors of ImmunityAllergy · 2026
16. GATA2 at 14: genotype-phenotype correlationsHaematologica · 2026
17. Clinical spectrum of Wiskott-Aldrich syndrome carriers: Self-reported survey of 193 carriersClinical Immunology · 2025
18. Proceedings of the Second Artificial Intelligence in Primary Immunodeficiencies (AIPI) MeetingJournal of Allergy and Clinical Immunology · 2025
19. Resolution of Squamous-Cell Carcinoma by Restoring T-Cell Receptor SignalingNew England Journal of Medicine · 2025
20. A novel frameshift mutation in Phosphoinositide 3-kinase regulatory subunit 1 ( PIK3R1 ) causes immunodeficiency and Amyotrophic Lateral Sclerosis (ALS)2025